chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 26 year old white female patient (previously reported as male) with no known allergies or medical history who on 6/10/04 was vaccinated SC with a first dose of varicella virus vaccine live (lot # 648300/0075P). Concomitant vaccination included a SC dose of MMR (lot # 646886/0949N) given on 5/27/04. Concomitant therapy included hormonal contraceptives (unspecified). There was no illness at the time of vaccination. WIthin fourteen days of vaccination, the patient developed a varicella like rash of about 20 spots around the site of injection. Within four days the spots were healed and mostly gone. Unspecified mediacl attention was sought and no treatment was required. There was no product quality complaint involved. Follow up information from the registered nurse indicated that the afternoon of 6/24/04, 14 days after vaccination with varicella virus vaccine live, the patient developed 10-15 tiny vesicles at the injection site and over her torso. It was also reported that the patient felt tired, developed a low grade fever, and experienced a headache, heat intolerance and photophobia. On 6/28/04, within four days of adverse event onset, all symptoms resolved. On 8/23/04, the patient was vaccinated with a second dose of varicella virus vaccine live and had no reaction at all. It was also reported that on 5/12/04 the patient was vaccinated with an IM second dose of hepatitis B vaccine (lot # 646144/0469N). It was noted that the patient recovered on 6/28/04. No further information is available.
Non stop Tingling all over my body.  Brain fog Numbness in my face periodically  Headaches  Nightmares
PATIENT RECEIVED THE VACCINE  AFTER 7HRS IN REFRIGERATOR AT 4C  INSTEAD OF 6HRS; POOR QUALITY DRUG ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced subject received the vaccine after 7hrs in refrigerator at 4c instead of 6hrs, and poor quality drug administered. The action taken with covid-19 vaccine  was not applicable. The outcome of the patient received the vaccine after 7 hrs in refrigerator at 4c instead of 6hrs and poor quality drug administered was not reported. This report was non-serious.
ACHES FOR ABOUT 2-3 DAYS; AWFUL NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported. The company was unable to follow-up request for batch number. No concomitant medications were reported. On an unspecified date, the subject experienced aches for about 2-3 days, and awful nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the awful nausea and aches for about 2-3 days was not reported. This report was non-serious.
bad pain in the arm; pain in the arm like can barely move it; little soreness; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9262 and expiry date: unknown), via an unspecified route of administration on 23Jan2021 at a single dose for COVID-19 immunization. Medical history included breast cancer. Concomitant medication included letrozole. Patient received the vaccine on Saturday and last night on 25Jan2021 and the morning of 26Jan2021, patient was having a very bad pain in the arm like can barely move it. She was fine until last night. She had a little soreness on Saturday (23Jan2021) and the night of 25Jan2021 and the morning of 26Jan2021, she can barely lift it. The pain was really a lot and patient did not know if this was normal. She knew that there was supposed to be some soreness right afterwards but this was like a day and a half later. Patient took TYLENOL as treatment for the events. Outcome of the events was unknown.
Pt received incorrect 2nd dose. She received Pfizer instead of Moderna, which was 1st dose. No symptoms and no expected negative outcomes. Dr notified of event. No new orders noted.
Extreme soreness at injection site, flu-like symptoms: fatigue, significant body aches/pains, nausea, mild headache, overall malaise. Lasted evening of day 1 through day 3.  800mg ibuprofen gave nearly complete symptom relief.
Ischemic stroke 3/15/21 (14 days after Moderna #1 administration)
on day 3 feverish, red, & very painful;hurts to raise arm;
About 5 hours after the shot I started experiencing extreme pain in my left elbow. the pain traveled down my arm and up my arm and eventually affected my back. The pain was so extreme that I could not use my arm for simple daily chores. There is a still bunch on my upper left arm - seven months later, the area of the injection.
Pain in left arm, everyday even with or without "usage".  Numbness feeling in both feet for the first 6 days.  Chest pains for the first few days.
Severe throat pain and ear pain, severe headache, dizziness, nausea, throat feels swollen.
Vomiting, & diarrhea x 2 days, self resolved; Then fever to 102F off & on x 7 days; Rash appeared on trunk, back arms & legs lasted x 5 days; Cried all day x 2 days; Mom states pt joints were sore, sl swelling in neck;
My right and left leg swelling up; Wondering; face is hurting on right side; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunization. Medical history included multiple sclerosis (MS), thyroid disorder. Concomitant medications included unspecified products. Patient experienced right and left leg swelling up; wondering; face is hurting on right side on an unspecified date. Patient went to "(city name)" (not clarified) the day prior for vaccination, took it about 5 o'clock and at the time of the report patient leg is swelling up the right and the left. And also patient face is hurting on the right side and patient have "MS" and patient was wondering what he/she should do. The outcome of the events was unknown.  Information about lot/Batch number has been requested.
About 3-4 hours after administration, pt got chills, fever temp=102 degrees F, nausea, projectile vomiting.
No additional AE; expired dose of GARDASIL-9; This spontaneous report was received from a pharmacist referring to a 41-year-old patient of unknown gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 17-MAY-2023, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (0.5 ml/ once, lot#: U007652, expiration date: 14-APR-2023; route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse event (AE) was reported (no adverse event).
approx 2 hrs p/receiving vax mom reports pt began to shake & eyes rolled back in head; This lasted 10 sec; afterwards pt wanted to go to sleep; mom called EMS; pt was transported to hosp ER; mom reports no fever prior to sz but @ ER t102.5;
Pfizer was not correctly diluted. Instead of 1.3 ml of Saline being diluted, 0.13 of saline was diluted with Pfizer. Patient received a more potent dose. Patient showed no adverse reactions. Patient was monitored for 15 minutes. Patient was stable.
rash on neck and face; This is a spontaneous report from Pfizer sponsored program COVAX US Support. A contactable female patient of an unspecified age received first dose of BNT162b2 (Covid shot, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration as a single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. Patient developed rash on neck and face after receiving first dose of COVID-19 vaccine. The outcome of the event was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 3 of 7; see case IDs A0924034A, A0924036A, A0924038A-A0924041A for details of the other reports.
shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, between 1 and 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle a week and a half after Shingles vaccination. The patient was informed that vaccine might had not been effective yet.
Muscle ache, muscle weakness, fever, fatigue, migraine, chills, night sweats. I took ibuprofen for the fever. Symptoms lasted for 4 days.
Left deltoid: edema, (^) warmth, reddened 3 inches x 3 inches, tenderness, sore muscle.
I am currently experiencing a swollen lymphnode in my left armpit which is the same arm that I received the vaccine in. This first presented around 11:00pm on Saturday 01/02/2021. I received my first dose of the moderna covid-19 vaccine on 12/28/2020. I did look on Moderna's website for further reaction information and it states that 4% of their test group reported this same symptom 5 to 7 days after first injection.
he can still feel where the injection was; very sensitive in one spot where they injected vaccine; area is a tad warm and swollen; tender to the touch; can feel it if he bumps or touches the injected area; high in bicep area where his shoulder and arm is connected in muscle/injection was kind of high in arm muscle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (he can still feel where the injection was), VACCINATION SITE HYPERSENSITIVITY (very sensitive in one spot where they injected vaccine), VACCINATION SITE WARMTH (area is a tad warm and swollen), VACCINATION SITE PAIN (tender to the touch) and VACCINATION SITE SWELLING (can feel it if he bumps or touches the injected area) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (he can still feel where the injection was), VACCINATION SITE HYPERSENSITIVITY (very sensitive in one spot where they injected vaccine), VACCINATION SITE WARMTH (area is a tad warm and swollen), VACCINATION SITE PAIN (tender to the touch), VACCINATION SITE SWELLING (can feel it if he bumps or touches the injected area) and VACCINATION SITE PAIN (high in bicep area where his shoulder and arm is connected in muscle/injection was kind of high in arm muscle). At the time of the report, VACCINATION SITE HYPOAESTHESIA (he can still feel where the injection was), VACCINATION SITE HYPERSENSITIVITY (very sensitive in one spot where they injected vaccine), VACCINATION SITE WARMTH (area is a tad warm and swollen), VACCINATION SITE PAIN (tender to the touch), VACCINATION SITE SWELLING (can feel it if he bumps or touches the injected area) and VACCINATION SITE PAIN (high in bicep area where his shoulder and arm is connected in muscle/injection was kind of high in arm muscle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Second dose scheduled on 25Apr2021.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
BURNING THROAT PAIN; DIFFICULTY IN SWALLOWING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced burning throat pain. On APR-2021, the subject experienced difficulty in swallowing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the burning throat pain and difficulty in swallowing was not reported. This report was non-serious.
Patient states she started to experience diaphoresis, vertigo, nausea and vomiting and chest pain. Was seen in ER and admitted on 9/14/2018 to 9/18/2018.
Blood came gushing out and pooled on floor after shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Blood came gushing out and pooled on floor after shot) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001192117 and IDMG2601) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Blood came gushing out and pooled on floor after shot). At the time of the report, VACCINATION SITE HAEMORRHAGE (Blood came gushing out and pooled on floor after shot) outcome was unknown.            No concomitant medications were reported. No treatment medication was reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
A couple of days after receiving the vaccine, I started having a metallic taste in my mouth. I have been to my primary care doctor, I have been to a gastroenterologist for an endoscopy, and I have had bloodwork done all results within normal range. I have tried numerous things to get rid of the taste and nothing helps. At this time, I am eliminating things to see if that will determine what is causing it. Also, I have never tested positive for COVID-19.
It was reported that a 2 year old female received 4th dose of DTaP vaccine on 7/24/02. Pt developed an 8cm x 8cm area of erythema and 4cm x 4cm induration to injection site on 7/25/02. No fever reported. Treated with warm packs and Keflex.
late for second dose; Covid-19; A spontaneous report (United states) was received from a pharmacist concerning patient who received Moderna's COVID-19 vaccine (mRNA-1273) late for second dose / Product dose omission issue because the patient developed COVID -19  The patient's medical history was not provided. Concomitant product use was not provided by reporter.   The patient was due to receive their second of two planned doses of mRNA-1273  (batch number not provided) on 08 Feb 2021.Due to having COVID, the patient missed the second dose. No treatment information was provided.   Action taken with the dose of mRNA-1273 vaccine was unknown.   The outcome for the event late for second dose / Product dose omission issue and COVID-19 was considered as unknown.; Reporter's Comments: This report refers to a case of a patient of unknown age and gender wo experienced   late for second dose or mRNA-1273 (Inappropriate schedule of vaccine administered) due COVID-19 infection. Based on the known etiology of the disease and the profile of mRNA-1273  vaccine, a causal association between the event and mRNA-1273 is assessed as unlikely.
Warm left leg; Red left leg; Itching left leg; Puked water; Sore arm; sore throat; warm head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VOMITING (Puked water), FEELING HOT (Warm left leg), ERYTHEMA (Red left leg) and PRURITUS (Itching left leg) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and FEELING HOT (warm head). On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 13-Apr-2021, the patient experienced VOMITING (Puked water). On 14-Apr-2021, the patient experienced FEELING HOT (Warm left leg), ERYTHEMA (Red left leg) and PRURITUS (Itching left leg). At the time of the report, PAIN IN EXTREMITY (Sore arm), VOMITING (Puked water), FEELING HOT (Warm left leg), ERYTHEMA (Red left leg), PRURITUS (Itching left leg), OROPHARYNGEAL PAIN (sore throat) and FEELING HOT (warm head) outcome was unknown. Not provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MODERNATX, INC.-MOD-2021-076582 (E2B Linked Report); Sender's Comments:  MODERNATX, INC.-MOD-2021-076582:CROSSLINKED WITH DOSE 1
Pt recvd Hep B vax on 24DEC91 & on 25DEC91 was adm to ER w/swollen rt arm which was dx as bursitis; No further details were provided;
Sore throat; eyes were burning; Slight fever; fever blisters on her lips; Very tired; Slept most of the day; Sore arm; deep bruise on her arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired), SOMNOLENCE (Slept most of the day), EYE IRRITATION (eyes were burning), PYREXIA (Slight fever) and ORAL HERPES (fever blisters on her lips) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm) and CONTUSION (deep bruise on her arm). On 16-Feb-2021, the patient experienced FATIGUE (Very tired) and SOMNOLENCE (Slept most of the day). On 17-Feb-2021, the patient experienced EYE IRRITATION (eyes were burning), PYREXIA (Slight fever) and ORAL HERPES (fever blisters on her lips). On 18-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; CELECOXIB (CELEBREX) at an unspecified dose and frequency and OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FATIGUE (Very tired), SOMNOLENCE (Slept most of the day), EYE IRRITATION (eyes were burning), PYREXIA (Slight fever), ORAL HERPES (fever blisters on her lips), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE PAIN (Sore arm) and CONTUSION (deep bruise on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications include were 2 antidepressants, several medications for her bowels, thyroid medicine, nerve pain medicine. stomach pills. The patient's medical history was not provided.
Patient described a "post-card sized" rash about 4 inches below the injection site starting 10d after the immunization. Denies pain, pruritis, bruising.
Complaining of continued pain and soreness in the muscle of the left arm in the deltoid region. Pain with deep palpation of the lymph nodes under the arm. Unable to sleep on that shoulder 2 weeks after the vaccine.
Rash, redness, heat, itching , hives and headache   seen  Jan ,11, 2021
First nose bleed ever and it was a big one.; This is a spontaneous report from a contactable male consumer(Patient). This consumer reported similar events for 2 patients. This report is for 1st of 2 patients.   A 30-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 11:00 (at the age of 30-years-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 for COVID-19 immunisation (Product: COVID 19, brand=Pfizer, Lot unknown: False, Administration date: 29Jan2021, Administration time: 05:00 PM, Vaccine location: Right arm, Dose number: 1). On 26Feb2021 02:00 it was reported the patient experienced First nose bleed ever and it was a big one. The patient did not receive treatment. The outcome of the event was recovered. The patient did not have COVID prior vaccination. The patient was not COVID tested post vaccination.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021260159 Same report/drug/AE, different patients
Administered hepatitis A vaccine to patient in error. New immunization registry (Immunization Registry, version 2-CARI2) produces a routing slip that does not distinguish between doses due on the day of the visit, as opposed to doses in the future. In spite of my practice of reviewing dates carefully and using a ruler to cross out doses due later, I gave the patient hepatitis A vaccine. I only noticed the error when entering the doses into the registry. Although I have filed a product update notice with the CAIR2 team, the only near-term solution to this problem is to slow down and carefully look at every "due date" and cross out those after the date of visit.